CRISPR Therapeutics, Castle Biosciences, and Selective Insurance Group received downward earnings estimate revisions on August 1, 2025.
2 reports, 1 independent
Updated Aug 1
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
CRISPR Therapeutics, Castle Biosciences, and Selective Insurance Group received downward earnings estimate revisions on August 1, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
CRISPR Therapeutics
company in Basel, Switzerland
Nothing else this week.
Coverage
Newest first; wire copies grouped- ZacksNew Strong Sell Stocks for August 1st Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: CRISPR Therapeutics AG CRSP is a gene editing company. The Zacks Consensus Estimate fo
- ZacksNew Strong Sell Stocks for July 29th Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: Burford Capital Limited BUR is a legal finance products and services company. The Zacks